Almost 300,000 women are to be offered a drug to reduce their risk of developing breast cancer, NHS officials have announced. Some 289,000 post-menopausal women in England who are deemed to have a moderate or high risk of breast cancer will be offered anastrozole in a bid to prevent them from developing the disease.
The drug is usually used to treat breast cancer but has been "repurposed" to also prevent cases. It is the first drug to go through NHS England's Medicines Repurposing Programme. "This is the first drug to be repurposed through a world-leading new programme to help us realise the full potential of existing medicines in new uses to save and improve more lives on the NHS. Thanks to this initiative, we hope that greater access to anastrozole could enable more women to take risk-reducing steps if they'd like to, helping them live without fear of breast cancer."
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: bbcemt - 🏆 120. / 51 Read more »